Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00988169
Brief Title: Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

First Submitted : September 30, 2009
First Submitted that Met QC Criteria : October 1, 2009
First Posted : October 2, 2009 (Estimate)

Results First Submitted : October 19, 2015
Results First Submitted that Met QC Criteria : October 19, 2015
Results First Posted : November 20, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : October 19, 2015
Last Update Posted : November 20, 2015 (Estimate)